WebOct 16, 2013 · Pancreatic cancer is the fourth leading cause of cancer-related death in Europe and the United States. 1,2 Since 1997, gemcitabine therapy has been the standard first-line treatment for... WebDec 2, 2004 · Gemcitabine (Gemzar) and paclitaxel are active drugs in the treatment of metastatic breast cancer. Phase I clinical trials data have suggested that the gemcitabine plus paclitaxel combination is safe in breast cancer patients.
Gemcitabine - an overview ScienceDirect Topics
WebSince the introduction of gemcitabine, pancreatic cancer may no longer be regarded a chemotherapy-resistant tumor. Treatment with single-agent gemcitabine achieved … WebKeywords: quality of life, stereotactic body radiation therapy, chemotherapy, gemcitabine, pancreatic cancer. Introduction. Pancreatic cancer has been the fourth leading cause of … hot pads weat bradenton
Abstract LB175: Ploidy as a predictive biomarker for gemcitabine ...
WebMar 15, 2024 · FIRST-LINE THERAPY A cisplatin-based combination chemotherapy regimen is the preferred initial therapy for patients with metastatic urothelial cancer of the bladder and urinary tract who are cisplatin candidates ( algorithm 1 ). WebJan 18, 2012 · Gemcitabine is a relatively new anticancer drug that has shown activity against bladder cancer. Objectives: To evaluate the effectiveness and toxicity of intravesical gemcitabine in preventing tumour recurrence and progression in non-muscle invasive bladder cancer (NMIBC). Search methods: The searches were from 1947 to May 2011. WebApr 11, 2024 · BackgroundThere are a variety of treatment options for recurrent platinum-resistant ovarian cancer, and the optimal specific treatment still remains to be determined. Therefore, this Bayesian network meta-analysis was conducted to investigate the optimal treatment options for recurrent platinum-resistant ovarian cancer.MethodsPubmed, … lindsey michelle photography nj